Date: 2011-03-08
Type of information: Collaboration agreement
Compound: protein expression products and systems
Company: ProteoNic (The Netherlands) Oxford Expression Technologies (UK)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: ProteoNic and Oxford Expression Technologies Ltd have joined forces in the field of recombinant protein production technology. The companies will be combining their proprietary technologies and tools (Unic™ translation enhancement elements from ProteoNic and flashBAC™ system, a baculovirus-based protein expression system from Oxford Expression Technologies) to further enhance protein yields through the synergistic effect of these two technologies.
Financial terms:
Latest news:
